Singleton Mark Leonard 4

4 · Bioventus Inc. · Filed Mar 17, 2026

AI-generated summary of this filing

Updated Mar 17, 2026

Bioventus (BVS) SVP/CFO Mark Singleton Exercises Options, Receives RSU Awards

What Happened

Mark Leonard Singleton, SVP & CFO of Bioventus Inc. (BVS), exercised/converted 13,500 derivative units into shares on 2026-03-13. To cover tax withholding related to the transaction, 5,865 shares were surrendered/withheld at $8.62 per share for a total of $50,556.
The filing also reports several equity awards (RSUs/options) granted to Singleton: 54,000 and 61,000 on 2025-03-14, and 104,000 and 116,000 on 2026-03-13 — a total of 335,000 award units (issued as derivatives/RSUs at $0 acquisition price).

Key Details

Transaction types/dates:
- 2026-03-13: Exercise/conversion of 13,500 derivative units (code M).
- 2026-03-13: 5,865 shares withheld/surrendered for tax liability at $8.62 each (code F), total $50,556.
- Grants (code A): 54,000 and 61,000 awarded on 2025-03-14; 104,000 and 116,000 awarded on 2026-03-13.
Shares owned after transaction: Not specified in the provided filing excerpt.
Footnotes: F1 — each RSU converts to one share of Class A common stock. F2/F3 — the RSUs/options vest in four equal annual installments beginning March 15, 2025 (for the 2025 awards) and March 15, 2026 (for the 2026 awards), subject to continued service.
Timeliness: The report covering a 2025-03-14 award was filed on 2026-03-17, indicating a late filing relative to the usual two-business-day Form 4 deadline.

Context

The 13,500-unit conversion appears to be an exercise/conversion of derivative awards; the withholding of 5,865 shares to cover taxes is a routine cashless tax-withholding action, not an open-market sale.
The large RSU/option grants are standard compensation awards that vest over four years and do not by themselves indicate immediate buying or selling intent.
These entries are compensation-related (awards and exercise/conversion) rather than discretionary open-market purchases by the insider.

Form 4

Period: 2025-03-14

SVP & CFO

Transactions

Exercise/Conversion
Class A Common Stock
2026-03-13+13,500→ 165,312 total
Tax Payment
Class A Common Stock
2026-03-13$8.62/sh−5,865$50,556→ 159,447 total
Award
Restricted Stock Units
[F1][F2]
2025-03-14+54,000→ 54,000 total
→ Class A Common Stock (54,000 underlying)
Award
Stock Option (Right to Buy)
[F2]
2025-03-14+61,000→ 61,000 total
Exercise: $9.61Exp: 2035-03-14→ Class A Common Stock (61,000 underlying)
Award
Restricted Stock Units
[F1][F3]
2026-03-13+104,000→ 104,000 total
→ Class A Common Stock (104,000 underlying)
Award
Stock Option (Right to Buy)
[F3]
2026-03-13+116,000→ 116,000 total
Exercise: $8.62Exp: 2036-03-13→ Class A Common Stock (116,000 underlying)
Exercise/Conversion
Restricted Stock Units
[F1][F2]
2026-03-13−13,500→ 40,500 total
→ Class A Common Stock (13,500 underlying)

Footnotes (3)

[F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
[F2]The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date.
[F3]The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date.

Signature

/s/ Anthony D'Adamio, Attorney-in-Fact|2026-03-17

1 file